title: Trial watch: Telomerase inhibitor shows promise in myeloproliferative disorders.
authors.forename: Megan
authors.initials: M
authors.lastname: Cully
mesh_terms: D000818:Animals; D017322:Clinical Trials, Phase II as Topic / Q000379:methods; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007211:Indoles / Q000494:pharmacology / Q000627:therapeutic use; D009196:Myeloproliferative Disorders / Q000188:drug therapy* / Q000201:enzymology*; D009536:Niacinamide / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D009841:Oligonucleotides; D019098:Telomerase / Q000037:antagonists & inhibitors* / Q000378:metabolism
chemical_list: D004791:Enzyme Inhibitors; D007211:Indoles; D009841:Oligonucleotides; D009536:Niacinamide; D019098:Telomerase; C519562:imetelstat